Helix Biopharma Corp banner

Helix Biopharma Corp
OTC:HBPCF

Watchlist Manager
Helix Biopharma Corp Logo
Helix Biopharma Corp
OTC:HBPCF
Watchlist
Price: 1.71 USD Market Closed
Market Cap: $419.1m

Intrinsic Value

The intrinsic value for Helix Biopharma Corp (HBPCF) under the Base Case is 0.24 USD. Compared with the current market price of 1.71 USD, the stock appears Overvalued by 86% .

Intrinsic value calculated using DCF
$0.24

Do our valuations actually work? See backtest results .

HBPCF Intrinsic Value
$0.24
Overvaluation 86%
Intrinsic Value
Price $1.71
Monitor HBPCF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $0.19
Get notified when the price drops into your buy zone
Current Price $1.71
Intrinsic Value $0.24
Margin of Safety 20% $0.19
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about HBPCF?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is HBPCF valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Helix Biopharma Corp.

Explain Valuation
Alternatives to HBPCF

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one HBPCF stock?

The intrinsic value for Helix Biopharma Corp (HBPCF) under the Base Case is 0.24 USD.

Is HBPCF stock undervalued or overvalued?

Compared with the current market price of 1.71 USD, the stock appears Overvalued by 86% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett